Inhibition of cellular 2′-5′ oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein

Journal of Virology

Volumn 81, Issue 7, 2007, Pages 3455-3464

  Sànchez, Ricardo ^a   Mohr, Ian ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; CELL PROTEIN; DOUBLE STRANDED RNA; GENE PRODUCT; INITIATION FACTOR 2ALPHA; INTERFERON; PACT PROTEIN; POLYPEPTIDE; PROTEIN KINASE R; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS US11 PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; ENZYME ACTIVATION; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; VIRUS GENE; VIRUS REPLICATION;

2',5'-OLIGOADENYLATE SYNTHETASE; CELL EXTRACTS; CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 1, HUMAN; HUMANS; PROTEIN BINDING; RNA, DOUBLE-STRANDED; RNA-BINDING PROTEINS; VIRAL PROTEINS;

HUMAN HERPESVIRUS 1;

EID: 33947357710     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02520-06     Document Type: Article

References (49)

1. Al-Khatib, K., B. R. Williams, R. H. Silverman, W. Halford, and D. J. Carr. 2003. The murine double-stranded RNA-dependent protein kinase PKR and the murine 2′,5′-oligoadenylate synthetase-dependent RNase L are required for IFN-beta-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture. Virology 313:126-135.
2. Austin, B. A., C. James, R. H. Silverman, and D. J. Carr. 2005. Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-B during acute ocular herpes simplex virus type 1 infection. J. Immunol. 175:1100-1106.
3. Beattie, E., K. L. Denzler, J. Tartaglia, M. E. Perkus, E. Paoletti, and B. L. Jacobs. 1995. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:499-505.
4. Cayley, P. J., J. A. Davies, K. G. McCullagh, and I. M. Kerr. 1984. Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase. Eur. J. Biochem. 143:165-174.
5. 134.5 protein of herpes simplex virus 1 have differential effects on viral response to interferon-α. Virology 307:290-300.
6. Chebath, J., P. Benech, M. Revel, and M. Vigneron. 1987. Constitutive expression of 2′-5′ oligo A synthetase confers resistance to picornavirus infection. Nature 330:587-588.
7. Child, S. J., M. Hakki, K. L. De Niro, and A. P. Geballe. 2004. Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J. Virol. 78:197-205.
8. DeLuca, N., and Schaffer, P. 1988. Physical and functional domains of the herpes simplex virus. J. Virol. 62:732-743.
9. Doepker, R. C., W.-L. Hsu, H. A. Saffran, and J. R. Smiley. 2004. Herpes simplex virus virion host shutoff protein is stimulated by translation initiation factors eIF4B and eIF4H. J. Virol. 78:4684-4699.
10. Duerst, R. J., and L. A. Morrison. 2004. Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness. Virology 322:158-167.
11. Eidson, K. M., W. E. Hobbs, B. J. Manning, P. Carlson, and N. A. DeLuca. 2002. Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J. Virol. 76:2180-2191.
12. Feng, P., D. N. Everly, Jr., and G. S. Read. 2005. mRNA decay during herpes simplex virus (HSV) infections: protein-protein interactions involving the HSV virion host shutoff protein and translation factors eIF4H and eIF4A. J. Virol. 79:9651-9664.
13. Floyd-Smith, G., E. Slattery, and P. Lengyel. 1981. Interferon action: RNA cleavage pattern of a 2′-5′ oligoadenylate-dependent endonuclease. Science 212:1030-1032.
14. Gribaudo, G., D. Lembo, G. Cavallo, S. Landolfo, and P. Lengyel. 1991. Interferon action: binding of viral RNA to the 40-kilodalton 2′-5′-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J. Virol. 65:1748-1757.
15. Har̈le, P., B. Sainz, Jr., D. J. Carr, and W. P. Halford. 2002. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. Virology 293:295-304.
16. Härle, P., V. Cull, M.-P. Agbaga, R. Silverman, B. R. G. Williams, C. James, and D. J. J. Carr. 2002. Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication. J. Virol. 76:6558-6567.
17. Hartmann, R., J. Justesen, S. N. Sarkar, G. C. Sen, and V. C. Yee. 2003. Crystal structure of the 2′-specific and double-stranded RNA-activated interferon-induced antiviral protein 2′-5′- oligoadenylate synthetase. Mol. Cell 12:1173-1185.
18. Hovanessian, A. G., J. Wood, E. Meurs, and L. Montagnier. 1979. Increased nuclease activity in cells treated with pppA2′p5′A2′ p5′ A. Proc. Natl. Acad. Sci. USA 76:3261-3265.
19. Jacquemont, B., and B. Roizman. 1975. RNA synthesis in cells infected with herpes simplex virus. X. Properties of viral symmetric transcripts and of double-stranded RNA prepared from them. J. Virol. 15:707-713.
20. Kajaste-Rudnitski, A., T. Mashimo, M. P. Frenkiel, J. L. Guenet, M. Lucas, and P. Despres. 2006. The 2′,5′ oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells. J. Biol. Chem. 281:4624-4637.
21. Kerr, I. M., and R. E. Brown. 1978. pppA2′p5′A2′ p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. USA 75:256-260.
22. Khabar, K. S., M. Dhalla, Y. Siddiqui, A. Zhou, M. N. Al-Ahdal, S. D. Der, R. H. Silverman, and B. R. Williams. 2000. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J. Interferon Cytokine Res. 20:653-659.
23. 23. Khoo, D., C. Perez, and I. Mohr. 2002. Characterization of RNA determinants recognized by the arginine- and proline-rich region of Us11, a herpes simplex virus type 1-encoded double-stranded RNA binding protein that prevents PKR activation. J. Virol. 76:11971-11981.
24. Kubota, K., K. Nakahara, T. Ohtsuka, S. Yoshida, J. Kawaguchi, Y. Fujita, Y. Ozeki, A. Hara, C. Yoshimura, H. Furukawa, H. Haruyama, K. Ichikawa, M. Yamashita, T. Matsuoka, and Y. Iijima. 2004. Identification of 2′-phosphodiesterase, which plays a role in the 2-5A system regulated by interferon. J. Biol. Chem. 279:37832-37841.
25. Langland, J. O., J. M. Cameron, M. C. Heck, J. K. Jancovich, and B. L. Jacobs. 2006. Inhibition of PKR by RNA and DNA viruses. Virus Res. 119:100-110.
26. Levy, D. E., I. Marie, and A. Prakash. 2003. Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr. Opin. Immunol. 15:52-58.
27. Lin, R., R. S. Noyce, S. E. Collins, R. D. Everett, and K. L. Mossman. 2004. The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J. Virol. 78:1675-1684.
28. Maitra, R. K., N. A. McMillan, S. Desai, J. McSwiggen, A. Hovanessian, G. Sen, B. R. Williams, and R. H. Silverman. 1994. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204:823-827.
29. Marie, I., J. Svab, N. Robert, J. Galabrn, and A. G. Hovanessian. 1990. Differential expression and distinct structure of 69- and 100-kDa forms of 2-5A synthetase in human cells treated with interferon. J. Biol. Chem. 265:18601-18607.
30. Melroe, G. T., N. A. DeLuca, and D. M. Knipe. 2004. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J. Virol. 78:8411-8420.
31. Min, J. Y., and R. Krug. 2006. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. USA 103:7100-7105.
32. Mohr, I., S. Sternberg, D. Ward, M. Leib, M. Mulvey, and Y. Gluzman. 2001. A herpes simplex virus type 1 γ34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals. J. Virol. 75:5189-5196.
33. Mohr, I. J., T. Pe'ery, and M. B. Mathews. 2006. Protein synthesis and translational control during viral infection. In N. Sonenberg, J. W. B. Hershey, and M. B. Mathews (ed.), Translational control. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
34. 134.5 gene products. J. Virol. 78:10193-10196.
35. Mulvey, M., J. Poppers, D. Sternberg, and I. Mohr. 2003. Regulation of eIF2α phosphorylation by different functions that act during discrete phases in the herpes simplex virus type 1 life cycle. J. Virol. 77:10917-10928.
36. Peters, G., D. Khoo, I. Mohr, and G. C. Sen. 2002. Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein. J. Virol. 76:11054-11064.
37. Poppers, J., M. Mulvey, C. Perez, D. Khoo, and I. Mohr. 2003. Identification of a lytic Epstein-Barr virus gene product that can regulate PKR activation. J. Virol. 77:228-236.
38. Poppers, J., M. Mulvey, D. Khoo, and I. Mohr. 2000. Inhibition of PKR activation by the proline-rich, RNA binding domain of the HSV-1 Us11 protein. J. Virol. 74:11215-11221.
39. Read, G. S., B. M. Karr, and K. Knight. 1993. Isolation of a herpes simplex virus type 1 mutant with a deletion in the virion host shutoff gene and identification of multiple forms of the vhs (UL41) polypeptide. J. Virol. 67:7149-7160.
40. Rebouillat, D., A. Hovnanian, I. Marie, and A. G. Hovanessian. 1999. The 100-kDa 2′,5′-oligoadenylate synthetase catalyzing preferentially the synthesis of dimeric pppA2′p5′A molecules is composed of three homologous domains. J. Biol. Chem. 274:1557-1565.
41. Rivas, C., J. Gil, Z. Melkova, M. Esteban, and M. Diaz-Guerra. 1998. Vaccinia virus E3L protein is an inhibitor of the interferon (i.fn.)-induced 2-5A synthetase enzyme. Virology 243:406-414.
42. Roller, R. J., and B. Roizman. 1992. The herpes simplex virus 1 RNA binding protein Us11 is a virion component and associates with 60S ribosomal subunits. J. Virol. 66:3624-3632.
43. Sarkar, S. N., and G. C. Sen. 2004. Novel functions of proteins encoded by viral stress-inducible genes. Pharmacol. Ther. 103:245-259.
44. Sarkar, S. N., and G. C. Sen. 1998. Production, purification and characterization of recombinant 2′5′-oligoadenylate synthetases. Methods 15:233-242.
45. Schmidt, A., Y. Chemajovsky, L. Shulman, P. Federman, H. Berissi, and M. Revel. 1979. An interferon-induced phosphodiesterase degrading (2′-5′) oligoisoadenylate and the C-C-A terminus of tRNA. Proc. Natl. Acad. Sci. USA 76:4788-4792.
46. Schreiber, E., P. Matthias, M. M. Müller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini extracts," prepared from a small number of cells. Nucleic Acids Res. 17:6419.
47. Sen, G. C. 2000. Novel functions of interferon-induced proteins. Semin. Cancer Biol. 10:93-101.
48. Silverman, R. H., D. D. Jung, N. L. Nolan-Sorden, C. W. Dieffenbach, V. P. Kedar, and D. N. SenGupta. 1988. Purification and analysis of murine 2-5A-dependent RNase. J. Biol. Chem. 263:7336-7341.
49. Wreschner, D. H., J. W. McCaule, J. J. Skehel, and I. M. Kerr. 1981. Interferon action sequence specificity of the ppp(A2′p)nA-dependent ribonuclease. Nature 289:414-417.